drug
exenatide
Phase 1updated 3mo agoby $ORMP ORAMED PHARMACEUTICALS INC.
Phase 1community read0 votes
indications
indications
Type 2 Diabetes
all catalysts(0)
nothing on the calendar yet
Trials studying exenatide
- —A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- phase1Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
- phase4Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
- phase4Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
- phase4GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
- N/AAn Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
- phase4FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)
- phase4Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DM
News(1)
- Opinion: The growing fang-to-pharmacy pipeline“Some of the most powerful medicines we will ever find are already here, carried in the fangs, stingers, and saliva of creatures we’ve been taught to fear,” writes Steve Midway.stat · 1mo ago
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that